Glanbia plc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Hugh McGuire Finance
- Full Time Employees
- 5,791
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- Glanbia House Kilkenny Ireland R95 E866
- IPO Date
- Oct 17, 2012
- Website
- glanbia.com
- Similar Companies
- Business
- Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland, specializing in the production, marketing, and distribution of dairy, nutritional, and food products. The company operates through three core divisions: Glanbia Performance Nutrition, which offers a portfolio of sports and lifestyle nutrition products including powders, bars, and ready-to-drink beverages marketed under brands such as Optimum Nutrition, BSN, Isopure, and Nutramino; Glanbia Nutritionals, which produces dairy and non-dairy nutritional and functional ingredients including cheese, nutritional premixes, plant-based protein solutions, flavor solutions, and bioactive nutrients for food and pharmaceutical industries; and Dairy Ireland and Joint Ventures, focusing on dairy production in Ireland. Glanbia serves diverse markets including sports nutrition, health and wellness, food and beverage manufacturing, and pharmaceuticals across over 130 countries, with North America as its largest market. Recent strategic developments include a group-wide transformation program launched in 2024 aimed at driving operational efficiencies and enabling scalable growth across three focused divisions: Performance Nutrition, Health & Nutrition, and Dairy Nutrition. This multi-year program targets annual cost savings of at least $50 million by 2027, with initiatives to optimize the operating model, unlock supply chain efficiencies, and accelerate digital transformation. In 2024, Glanbia completed the acquisition of Aroma Holding Company, a US-based flavoring business, strengthening its Health & Nutrition segment. The company also announced a €100 million share buyback authorization in 2024 and has committed to ongoing investment in growth and innovation. In early 2025, Glanbia confirmed its intention to sell the SlimFast brand, reflecting a strategic focus on core nutrition and dairy businesses. The company continues to expand product innovation and market presence with new product launches and a focus on sustainability. Founded in 1997, Glanbia plc operates globally with significant penetration in Europe, North America, Asia-Pacific, Latin America, and the Middle East. The company employs approximately 5,800 people and maintains headquarters and primary operations facilities in Ireland. Glanbia targets consumers, athletes, food manufacturers, and pharmaceutical companies, offering detailed product solutions in protein supplements, functional nutrition, nutritional premixes, dairy ingredients, and healthy lifestyle products. Its customer channels include specialty retail, digital commerce, gyms, foodservice, and industrial ingredient supply. This comprehensive portfolio and strategic focus position Glanbia as a major player in the global nutrition and dairy sectors, driving revenue growth through both organic innovation and targeted acquisitions. The company’s ongoing transformation efforts aim to enhance profitability, operational scalability, and sustainability performance across its geographically diversified operations. The company’s ticker symbol is GLAPY, and it is listed primarily on Euronext Dublin. Glanbia’s leadership emphasizes financial discipline alongside growth, aiming for strategic investments that deliver at least 12% after-tax return within three years. Its latest financial performance reflects expanding revenues and improving margins, driven by volume growth, pricing strategies, and acquisitions within a resilient global nutrition market.
Is Glanbia (GLAPY) Stock Outpacing Its Consumer Staples Peers This Year?
Longleaf Partners Global Fund Q1 2026 Portfolio Review
Glanbia plc (GLAPY) Q4 2025 Earnings Call Transcript
Glanbia plc (GLAPY) Analyst/Investor Day Transcript
Glanbia plc (GLAPY) Q3 2025 Earnings Call Transcript
Longleaf Partners Global Fund Q3 2025 Notable Contributors & Detractors
Head to Head Survey: Glanbia (OTCMKTS:GLAPY) vs. China Mengniu Dairy (OTCMKTS:CIADY)
Glanbia to sell Slimfast US to Heartland Food Products group of US
Glanbia plc (GLAPF) Q2 2025 Earnings Call Transcript
Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More
Glanbia shares jump after 'better than feared' first quarter
Glanbia plc (GLAPF) 2024 Full Year Results Earnings Call Transcript
Supplements producer Glanbia's shares dive on profit warning
Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript
Glanbia: Fairly Valued For Current Performance
Glanbia plc (GLAPF) Q2 2023 Earnings Call Transcript
Glanbia plc (GLAPF) Q4 2022 Earnings Call Transcript
Glanbia plc's (GLAPF) Q4 2021 Results - Earnings Call Transcript
Glanbia looks healthy after Irish disposal and buyback plan
Here's Why "Trend" Investors Would Love Betting on Glanbia Plc ADR (GLAPY)